Feasibility of Pathology-Correlated Lung Imaging for Accurate Target Definition of Lung Tumors
- 1 September 2007
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 69 (1) , 267-275
- https://doi.org/10.1016/j.ijrobp.2007.04.065
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal VolumesInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Final results of a Phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosisInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysisInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non–small-cell lung cancer?International Journal of Radiation Oncology*Biology*Physics, 2005
- Defining a radiotherapy target with positron emission tomographyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Improved local control with higher doses of radiation in large-volume stage III non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Wedge Resection Margin Distances and Residual Adenocarcinoma in Lobectomy SpecimensAmerican Journal of Clinical Pathology, 2003
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI Journal of the National Cancer Institute, 1996